ETON PHARMACEUTICALS INC. - COMMON STOCK
16,42
14-февраля-25 12:28:10
15 мин. задержка
Акции
-0,39
-2,32%
Сегодняшний диапазон
16,42 - 16,91
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
14 мар 2024 16:01:00 Источник Nasdaq GlobeNewswire
-
29 фев 2024 16:01:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
21 фев 2024 06:50:00 Источник Nasdaq GlobeNewswire
-
02 фев 2024 06:50:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
09 ноя 2023 16:01:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
30 окт 2023 06:50:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone
04 окт 2023 06:50:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
23 авг 2023 06:50:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results
10 авг 2023 16:01:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023
01 авг 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection
28 июн 2023 06:50:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports First Quarter 2023 Financial Results
11 май 2023 16:01:01 Источник Nasdaq GlobeNewswire
-
10 май 2023 06:50:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
03 май 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
16 мар 2023 16:01:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600
15 мар 2023 06:50:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023
07 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection
11 янв 2023 06:50:00 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results
10 ноя 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
02 ноя 2022 16:05:00 Источник Nasdaq GlobeNewswire